GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

The growing popularity of GLP-1 agonists for weight management has sparked a surge in alternative dosing methods, particularly microdosing of Ozempic. This emerging practice involves intentionally ...

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes ...

Incretin mimetics are revolutionizing obesity treatment, but high prices and supply shortages limit patient access. Some clinicians have suggested less frequent dosing as an off-ramping strategy to ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs ... Some pens are single-use and contain a premeasured dose of the GLP-1 RA. In other cases, you select the amount of medication to be injected.

But if you are already taking insulin, you may be able to decrease your dose (or maybe stop it completely) if taking a GLP-1 agonist is effective, Neumiller says. Work with your healthcare team to ...

For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased risk for psychiatric adverse events or worsening ...

In GLP-1 receptor agonist-naive patients starting the generic liraglutide, once daily, adherence may not be a concern. However, for people who may switch from a once-weekly to a once-daily dosing ...

The small-scale, 28-day study saw 36 healthy adults with obesity or overweight receive one of three oral doses of the GLP-1 agonist ... 740 mg, dose of TERN-601 saw a placebo-adjusted mean ...

They also highlight the need for future clinical trials to more conclusively determine the dose and duration of GLP-1 receptor agonist-based treatments in patients addicted to different types of ...